Associations of cigarette smoking, e-cigarette use, and dual use with newly diagnosed arthritis: a longitudinal cohort analysis

Introduction Cigarette smoking is an established risk factor for rheumatoid arthritis, but longitudinal evidence on e-cigarette use, dual use, and broader arthritis outcomes remains limited. We examined whether baseline cigarette and e-cigarette use status was associated with newly diagnosed arthritis reported at follow-up. Methods We analysed data from the UK Household Longitudinal Study (UKHLS) among participants who did not report a previous arthritis diagnosis at Wave 10 (2018–2019; baseline). Baseline cigarette and e-cigarette use was classified into four mutually exclusive groups: neither current cigarette nor e-cigarette use, exclusive current cigarette use, exclusive current e-cigarette use, and dual use. The outcome was newly diagnosed arthritis reported at Wave 14 (2022–2023; follow-up). Modified Poisson regression with robust standard errors was used to estimate risk ratios (RRs) and 95% confidence intervals. Adjusted models included age modelled using a four-knot restricted cubic spline, sex, ethnicity, rural–urban residence, and highest educational qualification. Sensitivity analyses additionally adjusted for alcohol use and fruit and vegetable intake measured at Wave 9, excluded participants who reported arthritis at Waves 11–13, and applied stricter e-cigarette-use definitions. Results Among 18,802 participants included in the primary analysis, 587 (3.12%) reported newly diagnosed arthritis at Wave 14. The unadjusted proportions were 3.05% among participants reporting neither current cigarette nor e-cigarette use, 3.83% among exclusive cigarette users, 2.21% among exclusive e-cigarette users, and 4.47% among dual users (overall p = 0.064). Compared with participants reporting neither current cigarette nor e-cigarette use, exclusive cigarette use was associated with a higher adjusted risk of newly diagnosed arthritis (RR 1.43, 95% CI 1.11–1.84; p = 0.005), as was dual use (RR 1.79, 95% CI 1.10–2.90; p = 0.019). Exclusive e-cigarette use was not associated with newly diagnosed arthritis (RR 1.01, 95% CI 0.61–1.68; p = 0.965). Compared with the primary analysis, estimates were similar after additional adjustment for alcohol use and fruit and vegetable intake (exclusive cigarette use: RR 1.39, 95% CI 1.06–1.82; p = 0.017; dual use RR 1.79, 95% CI 1.09–2.94; p = 0.022) and after excluding participants who reported arthritis at Waves 11–13 (exclusive cigarette use: RR 1.50, 95% CI 1.09–2.06; p = 0.012; dual use: RR 1.92, 95% CI 1.03–3.57; p = 0.040). When e-cigarette use was restricted to at least monthly or weekly use, the association for exclusive cigarette use remained stable, exclusive e-cigarette use showed no evidence of an association, and the dual-use estimates were attenuated and less precise. Conclusions Exclusive cigarette smoking and dual cigarette-e-cigarette use were associated with a higher risk of newly diagnosed arthritis in the primary analysis. No association was identified for exclusive e-cigarette use, although precision was limited. Studies with clinically verified arthritis outcomes, repeated exposure assessment, and stronger control of cumulative smoking and adiposity are needed. Key Points • Exclusive cigarette use was associated with a 43% higher adjusted risk of newly diagnosed arthritis. • Dual cigarette and e-cigarette use was associated with a 79% higher adjusted risk in the primary analysis. • Exclusive e-cigarette use was not associated with newly diagnosed arthritis, but the estimate was imprecise. • Dual-use estimates weakened when e-cigarette use was restricted to at least monthly or weekly use.

Authors

Institutions

Publication Details

Journal
Clinical Rheumatology
Published
2026-11-19
DOI
https://doi.org/10.1007/s10067-026-08544-7
Primary Topic
Smoking Behavior and Cessation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Associations of cigarette smoking, e-cigarette use, and dual use with newly diagnosed arthritis: a longitudinal cohort analysis

Isaac Olushola Ogunkola, Yusuff Adebayo Adebisi, Maleek Olanrewaju Olatunji, Don Eliseo Lucero‐Prisno et al.
Clinical Rheumatology
Smoking Behavior and Cessation
article

Associations of cigarette smoking, e-cigarette use, and dual use with newly diagnosed arthritis: a longitudinal cohort analysis

Isaac Olushola Ogunkola, Yusuff Adebayo Adebisi, Maleek Olanrewaju Olatunji, Don Eliseo Lucero‐Prisno, Anas Ali Alhur, Henry Eziefule Nwankwo
article en

Abstract

Introduction Cigarette smoking is an established risk factor for rheumatoid arthritis, but longitudinal evidence on e-cigarette use, dual use, and broader arthritis outcomes remains limited. We examined whether baseline cigarette and e-cigarette use status was associated with newly diagnosed arthritis reported at follow-up. Methods We analysed data from the UK Household Longitudinal Study (UKHLS) among participants who did not report a previous arthritis diagnosis at Wave 10 (2018–2019; baseline). Baseline cigarette and e-cigarette use was classified into four mutually exclusive groups: neither current cigarette nor e-cigarette use, exclusive current cigarette use, exclusive current e-cigarette use, and dual use. The outcome was newly diagnosed arthritis reported at Wave 14 (2022–2023; follow-up). Modified Poisson regression with robust standard errors was used to estimate risk ratios (RRs) and 95% confidence intervals. Adjusted models included age modelled using a four-knot restricted cubic spline, sex, ethnicity, rural–urban residence, and highest educational qualification. Sensitivity analyses additionally adjusted for alcohol use and fruit and vegetable intake measured at Wave 9, excluded participants who reported arthritis at Waves 11–13, and applied stricter e-cigarette-use definitions. Results Among 18,802 participants included in the primary analysis, 587 (3.12%) reported newly diagnosed arthritis at Wave 14. The unadjusted proportions were 3.05% among participants reporting neither current cigarette nor e-cigarette use, 3.83% among exclusive cigarette users, 2.21% among exclusive e-cigarette users, and 4.47% among dual users (overall p = 0.064). Compared with participants reporting neither current cigarette nor e-cigarette use, exclusive cigarette use was associated with a higher adjusted risk of newly diagnosed arthritis (RR 1.43, 95% CI 1.11–1.84; p = 0.005), as was dual use (RR 1.79, 95% CI 1.10–2.90; p = 0.019). Exclusive e-cigarette use was not associated with newly diagnosed arthritis (RR 1.01, 95% CI 0.61–1.68; p = 0.965). Compared with the primary analysis, estimates were similar after additional adjustment for alcohol use and fruit and vegetable intake (exclusive cigarette use: RR 1.39, 95% CI 1.06–1.82; p = 0.017; dual use RR 1.79, 95% CI 1.09–2.94; p = 0.022) and after excluding participants who reported arthritis at Waves 11–13 (exclusive cigarette use: RR 1.50, 95% CI 1.09–2.06; p = 0.012; dual use: RR 1.92, 95% CI 1.03–3.57; p = 0.040). When e-cigarette use was restricted to at least monthly or weekly use, the association for exclusive cigarette use remained stable, exclusive e-cigarette use showed no evidence of an association, and the dual-use estimates were attenuated and less precise. Conclusions Exclusive cigarette smoking and dual cigarette-e-cigarette use were associated with a higher risk of newly diagnosed arthritis in the primary analysis. No association was identified for exclusive e-cigarette use, although precision was limited. Studies with clinically verified arthritis outcomes, repeated exposure assessment, and stronger control of cumulative smoking and adiposity are needed. Key Points • Exclusive cigarette use was associated with a 43% higher adjusted risk of newly diagnosed arthritis. • Dual cigarette and e-cigarette use was associated with a 79% higher adjusted risk in the primary analysis. • Exclusive e-cigarette use was not associated with newly diagnosed arthritis, but the estimate was imprecise. • Dual-use estimates weakened when e-cigarette use was restricted to at least monthly or weekly use.

Clinical Rheumatology
University of London (GB), University of Chester (GB), University of Ibadan (NG), University of Bristol (GB), University of Oxford (GB), University of Ha'il (SA), London School of Hygiene & Tropical Medicine (GB), University of Glasgow (GB)
Smoking Behavior and Cessation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon